ConductScience.org, home

Paper42872064PubMed

HMGB1 functional plasticity in neurodegenerative diseases and its translational implications.

Cai W and 7 others. Front Immunol, 2026.

Cite this record

ConductScience Library. HMGB1 functional plasticity in neurodegenerative diseases and its translational implications. Papers, record 42872064. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42872064

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
HMGB1 functional plasticity in neurodegenerative diseases and its translational implications.
Journal
Front Immunol
Year
2026
Publication types
Journal Article, Review, Research Support, Non-U.S. Gov't
Revised in PubMed
2026-10-27

Source PubMed

Authors8

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cai WWeicai
2Yi YYaqiao
3Zeng RRong
4Yin YYitong
5Zhao JJiayue
6Zhang JJieyang
7Fu GGuilong
8Xu HHui

Source PubMed

Download CSV of authors

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
HMGB1 ProteinMajor topic
Neurodegenerative DiseasesMajor topic
Humans
Animals
Translational Research, Biomedical
Signal Transduction
Alarmins
Biomarkers

Source PubMed

Download CSV of topics

References101

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
140273909Transcriptional regulation by PHGDH drives amyloid pathology in Alzheimer's disease.Cell2025https://conductscience.org/library/papers/40273909PubMed
237571393Underlying Mechanisms of Brain Aging and Neurodegenerative Diseases as Potential Targets for Preventive or Therapeutic Strategies Using Phytochemicals.Nutrients2023https://conductscience.org/library/papers/37571393PubMed
334253711Circulating HMGB1 is elevated in veterans with Gulf War Illness and triggers the persistent pro-inflammatory microglia phenotype in male C57Bl/6J mice.Transl Psychiatry2021https://conductscience.org/library/papers/34253711PubMed
415597044alpha-Synuclein filaments bind the transcriptional regulator HMGB-1.Neuroreport2004https://conductscience.org/library/papers/15597044PubMed
520123072HMGB proteins: interactions with DNA and chromatin.Biochim Biophys Acta2010https://conductscience.org/library/papers/20123072PubMed
632706028HMGB1 A box protects neurons by potently inhibiting both microglia and T cell-mediated inflammation in a mouse Parkinson's disease model.Clin Sci (Lond)2020https://conductscience.org/library/papers/32706028PubMed
723639787Elevated serum autoantibody against high mobility group box 1 as a potent surrogate biomarker for amyotrophic lateral sclerosis.Neurobiol Dis2013https://conductscience.org/library/papers/23639787PubMed
835348636The bidirectional lung brain-axis of amyloid-β pathology: ozone dysregulates the peri-plaque microenvironment.Brain2023https://conductscience.org/library/papers/35348636PubMed
912765338Structural basis for the proinflammatory cytokine activity of high mobility group box 1.Mol Med2003https://conductscience.org/library/papers/12765338PubMed
1038624088Peripheral HMGB1 is linked to O3 pathology of disease-associated astrocytes and amyloid.Alzheimers Dement2024https://conductscience.org/library/papers/38624088PubMed
1140385486Randomized, double-blind, placebo-controlled pilot study of metformin as an adjunctive therapy in Parkinson's disease.Front Pharmacol2025https://conductscience.org/library/papers/40385486PubMed
1230210286Dysregulation of Astrocytic HMGB1 Signaling in Amyotrophic Lateral Sclerosis.Front Neurosci2018https://conductscience.org/library/papers/30210286PubMed
1329676481High-mobility group box 1 in Parkinson's disease: from pathogenesis to therapeutic approaches.J Neurochem2018https://conductscience.org/library/papers/29676481PubMed
1410398600HMG-1 as a late mediator of endotoxin lethality in mice.Science1999https://conductscience.org/library/papers/10398600PubMed
1515499593High mobility group box protein-1 inhibits microglial Abeta clearance and enhances Abeta neurotoxicity.J Neurosci Res2004https://conductscience.org/library/papers/15499593PubMed
1636566881Glycyrrhizin prevents 3-nitropropionic acid-induced neurotoxicity by downregulating HMGB1/TLR4/NF-κB p65 signaling, and attenuating oxidative stress, inflammation, and apoptosis in rats.Life Sci2023https://conductscience.org/library/papers/36566881PubMed
1718631454Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein.Immunity2008https://conductscience.org/library/papers/18631454PubMed
1836388178HMGB1 in nervous system diseases: A common biomarker and potential therapeutic target.Front Neurol2022https://conductscience.org/library/papers/36388178PubMed
1933876503Intracellular amyloid hypothesis for ultra-early phase pathology of Alzheimer's disease.Neuropathology2021https://conductscience.org/library/papers/33876503PubMed
2031563843Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: Implications in DNA repair and immune responses.DNA Repair (Amst)2019https://conductscience.org/library/papers/31563843PubMed

See all 101 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42872064

GET https://conductscience.org/api/papers/v1/42872064/references?page=2